FDA recall announcement
Nara Infant Formula recall 2026
Nara Organics voluntarily recalled all lots of its powdered infant formula currently on the market because of a potential botulism risk.
Potential risk of Clostridium botulinum contamination.
- FDA publish date
- June 13, 2026
- Company
- Nara Organics
- Product
- Nara Organics Whole Milk Powdered Infant Formula, 400 g and 700 g
- Last checked
- September 23, 2026
- NDC / identifier
- UPC 860013251901, UPC 860013251918
- Affected lot(s)
- 408125075E14F2, 708125076E14F2, 708125083E14F2, 408125139E14F2, 708125141E14F2, 708125145E14F2, 708125174E14F2, 709125273E14F2, 709125280E14F2, 709125288E14F2, 409125307E14F2, 70926019ENNB, 70926029ENNB, 70926035ENNB, 70926039ENNB, 70926042ENNB
What the FDA announcement says
Potential risk of Clostridium botulinum contamination.
Read the original FDA Nara infant formula recall announcement →
What to check on the package
- Confirm the exact product and brand name.
- Compare the manufacturer or distributor.
- Match the NDC or product identifier.
- Match the lot or code exactly; a drug name alone is not enough.
What to do
Stop using affected formula immediately. If an infant consumed it and has concerning symptoms, contact a healthcare provider for immediate care.
Related FDA enforcement records
No matching record was found in the current openFDA enforcement snapshot. FDA announcements can appear before a classified enforcement record reaches the dataset.
Search all records for Nara Infant Formula →
Source and limitations
This server-rendered page summarizes an FDA source and the openFDA enforcement snapshot last checked on September 23, 2026. It is not an FDA service and does not provide individual medical advice.